Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-020721

Director sold 10,800 shares at $3.40 ($36,720)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WILSON TROY EDWARD Director 2025-06-13 Sale 10b5-1 −10,800 $3.40 $36,720 43,550 D
Open-market sales · 10,800 sh · avg $3.40 · $36,720
Loading xslF345X05/rdgdoc.xml…